News

Nanalysis Announces First Quarter 2025 Conference Call
Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR instruments and ...
Muscular Dystrophy News34m
DMD gene therapy Elevidys wins conditional approval in Japan
The approval allows the DMD gene therapy to be sold in Japan for up to seven years, but more trials will be needed for full ...